Natl Toxicol Program Tech Rep Ser. 1997 Apr;463:1-190.
D&C Yellow No. 11 is used to color topical drug preparations and cosmetics. It is also used in spirit lacquers, polystyrenes, polycarbonates, polyamides, acrylic resins, colored smokes, and hydrocarbon solvents. D&C Yellow No. 11 was nominated to the NTP for toxicity and carcinogenesis studies as part of a larger regulatory effort mandated by Congress and undertaken by the Food and Drug Administration to determine the safety of a number of provisionally listed dyes. D&C Yellow No. 11 is currently regulated for external use. The recommendation to study D&C Yellow No. 11 by dietary exposure was based on the fact that it is a contaminant of D&C Yellow No. 10, a candidate for permanent listing as a chemical for which there is a potential for ingestion. First-generation (F(0)) male and female F344/N rats were given D&C Yellow No. 11 (approximately 99% pure) in feed for up to 19 weeks and then mated, and exposure of second-generation (F(1)) males and females began in utero and continued for 2 years after weaning at 28 days of age. Genetic toxicology studies were conducted in Salmonella typhimurium, cultured Chinese hamster ovary cells, and mouse peripheral blood. REPRODUCTIVE TOXICITY STUDY: Groups of 60 male and 60 female F(0) rats were given 0, 500, 1,700, or 5,000 ppm D&C Yellow No. 11 in feed for up to 19 weeks, which resulted in average daily doses of 35, 120, or 350 mg D&C Yellow No. 11/kg body weight to males and 35, 120, or 370 mg/kg to females. All F(0) males and females survived until the end of the study. Prior to cohabitation, mean body weight gains of males given 500, 1,700, or 5,000 ppm and of females given 5,000 ppm were significantly lower than those of the controls. The mean body weight gains of exposed females during gestation and lactation were generally similar to those of the controls. Feed consumption by exposed groups of rats was generally similar to that by the control groups prior to cohabitation. The duration of gestation, the average litter size, the number of live pups on days 4 (precull) and 21, and the percentage of male pups for each exposure group were similar to those of the controls. The mean body weights of exposed litters were significantly less than those of the control litters on days 14 and 21; this effect was considered to be related to D&C Yellow No. 11 exposure. 2-YEAR STUDY: Groups of 60 male and 60 female F(1) rats were given 0, 500, 1,700, or 5,000 ppm D&C Yellow No. 11 in feed for 105 (males) or 106 (females) weeks after weaning (day 28); 6 to 10 rats per group were evaluated at 12 months. These exposure concentrations resulted in average daily doses of approximately 25, 85, or 250 mg D&C Yellow No. 11/kg body weight to males and 25, 100, or 280 mg/kg to females. Survival, Body Weights, Feed Consumption, and Clinical Findings: Survival of males given 1,700 or 5,000 ppm was significantly less than that of the controls, and survival of 1,700 ppm females was significantly greater than that of the controls. Mean body weights of 1,700 and 5,000 ppm males and females were generally lower than those of the controls throughout the study. Feed consumption by exposed groups was similar to that by the controls. Chemical-related clinical findings included yellow discoloration of the entire body in all exposed males and females from day 1 and head swelling and edema in 1,700 and 5,000 ppm males. One 1,700 ppm and five 5,000 ppm males were moribund and were killed between weeks 49 and 81; these deaths were attributed to extensive edema. Hematology: A few minimal hematology changes occurred in male rats at the 12-month interim evaluation. There was evidence of minimal anemia in exposed males; this anemia was characterized by decreased hematocrit values, hemoglobin concentrations, and erythrocyte counts. The minimal anemia was characterized as normocytic, normochromic, and nonresponsive. There were no biologically or statistically significant differences in hematology parameters between control and exposed females. Pathology Findings: Absolute and relative liver weights of all exposed groups of md relative liver weights of all exposed groups of males and females were significantly greater than those of the controls at 12 months. At 2 years, the incidences of hepatocellular adenoma in 5,000 ppm males and of hepatocellular adenoma or carcinoma (combined) in 5,000 ppm females were significantly greater than those in the controls. At 12 months, the incidences of clear cell foci in 1,700 and 5,000 ppm females were significantly greater than that in the controls. At 2 years, the incidences of mixed cell foci in exposed males and of clear cell foci in exposed males (except 500 ppm) and females were significantly greater than those in the controls. Incidences of cytologic alterations (basophilia and granularity) of hepatocytes, and pigmentation in bile duct epithelium, hepatocytes, and Kupffer cells in exposed males and females were greater than those in the controls at both 12 months and 2 years. Renal tubule adenomas were observed in two 5,000 ppm males, and one renal tubule carcinoma was observed in a 1,700 ppm male. During an extended evaluation, renal tubule adenomas were observed in two additional 5,000 ppm males, four 1,700 ppm males, and two 500 ppm males. Renal tubule hyperplasia was observed in exposed groups of males but not in controls, and the incidences in 1,700 ppm males from both standard and extended evaluations were significantly greater than those in the controls. Necrosis and regeneration of the renal tubule epithelium were observed in all control and exposed male rats and in most female rats at 12 months and 2 years. The severity of nephropathy in exposed males and females was significantly greater than that in the controls. In exposed males and 1,700 ppm females at 2 years, the incidences of hyperplasia of the transitional epithelium in the kidney, which commonly accompanies advanced nephropathy, were greater than those of the controls, and the severity of this lesion in exposed males and females was greater than that in the controls. The incidences of renal tubule pigmentation in all exposed groups of males and females at 12 months and 2 years were significantly greater than those in the controls. Squamous cell carcinomas of the tongue were observed in one 500 ppm male at 12 months and one 5,000 ppm female at 2 years, and one squamous cell carcinoma of the oral mucosa was observed in each group of exposed males and in one 5,000 ppm female at 2 years. At 2 years, squamous cell papillomas were observed in the oral cavity (oral mucosa or tongue) of one control, one 500 ppm, two 1,700 ppm, and four 5,000 ppm males; this lesion was also observed in one control and one 500 ppm female. GENETIC TOXICOLOGY: Results of mutagenicity tests with D&C Yellow No. 11 in Salmonella typhimurium were equivocal in one study, based on responses observed in strain TA100 with induced rat liver S9, and weakly positive in a second study, based on responses observed in strains TA98 and TA100 with induced rat or hamster liver S9. D&C Yellow No. 11 induced sister chromatid exchanges and chromosomal aberrations in cultured Chinese hamster ovary cells, with and without S9. No increase in the frequency of micronucleated normochromatic erythrocytes was observed in peripheral blood samples from male and female B6C3F(1) mice administered D&C Yellow No. 11 in feed for 13 weeks. CONCLUSIONS: Under the conditions of this perinatal exposure followed by a 2-year dosed feed study, there was some evidence of carcinogenic activity of D&C Yellow No. 11 in male F344/N rats based on increased incidences of hepatocellular adenoma, renal tubule neoplasms, and squamous cell neoplasms of the oral cavity. There was some evidence of carcinogenic activity in female F344/N rats based on increased inci dences of hepatocellular neoplasms. Incidences of uncommon squamous cell carcinoma of the oral cavity in females may have been related to chemical treatment. Exposure of rats to D&C Yellow No. 11 in feed for 2 years resulted in increased incidences of nonneoplastic liver lesions including clear cell foci, increased basophilia and granularity in the cytoplasm of hepatocytes, and bile duct, hepatocyte, and Kupffer cell pigmentation in males and females and mixed cell foci in males. In the kidney, there were increased incidences of renal tubule pigmentation and transitional epithelial hyperplasia in males and females and renal tubule hyperplasia in males. The severity of nephropathy was increased in exposed males and females. Synonyms: 2-(2-Quinolinyl)-1H-indene-1,3-(2H)-dione; 2-(2-quinolyl)-1,3-indandione Trade names: Arlosol Yellow S, Chinoline Yellow D (soluble in spirits), Chinoline Yellow ZSS, C.I. 47000, C.I. Solvent Yellow 33, Nitro Fast Yellow SL, Oil Yellow SIS, Petrol Yellow C, Quinoline Yellow A Spirit Soluble, Quinoline Yellow Base, Quinoline Yellow Spirit Soluble, Quinoline Yellow SS, Solvent Yellow 33, Waxoline Yellow T
D&C 黄 11 号用于给局部用药物制剂和化妆品着色。它还用于硝基漆、聚苯乙烯、聚碳酸酯、聚酰胺、丙烯酸树脂、彩色烟雾和烃类溶剂中。作为国会授权、由食品药品监督管理局开展的一项更大规模监管工作的一部分,D&C 黄 11 号被提名为进行毒性和致癌性研究的物质,该监管工作旨在确定一些临时列出的染料的安全性。D&C 黄 11 号目前规定仅供外用。建议通过饮食暴露来研究 D&C 黄 11 号,是基于它是 D&C 黄 10 号的污染物这一事实,D&C 黄 10 号是一种有可能被摄入的化学品,正在申请永久列入清单。第一代(F(0))雄性和雌性 F344/N 大鼠在饲料中摄入 D&C 黄 11 号(纯度约为 99%)长达 19 周,然后进行交配,第二代(F(1))雄性和雌性大鼠在子宫内就开始接触该物质,并在 28 日龄断奶后持续接触 2 年。在鼠伤寒沙门氏菌、培养的中国仓鼠卵巢细胞和小鼠外周血中进行了遗传毒理学研究。
将 60 只雄性和 60 只雌性 F(0)大鼠分为几组,在饲料中给予 0、500、1700 或 5000 ppm 的 D&C 黄 11 号,持续 19 周,这导致雄性大鼠的平均每日剂量为 35、120 或 350 mg D&C 黄 11 号/千克体重,雌性大鼠为 35、120 或 370 mg/千克。所有 F(0)雄性和雌性大鼠均存活至研究结束。在同居前,给予 500、1700 或 5000 ppm 的雄性大鼠以及给予 5000 ppm 的雌性大鼠的平均体重增加显著低于对照组。暴露雌性大鼠在妊娠和哺乳期的平均体重增加通常与对照组相似。暴露组大鼠在同居前的饲料消耗量通常与对照组相似。各暴露组的妊娠期、平均窝仔数、第 4 天(预淘汰)和第 21 天的存活幼仔数以及雄性幼仔的百分比与对照组相似。在第 14 天和第 21 天,暴露窝仔的平均体重显著低于对照窝仔;这种影响被认为与接触 D&C 黄 11 号有关。
将 60 只雄性和 60 只雌性 F(1)大鼠分为几组,在断奶(第 28 天)后,在饲料中给予 0、500、1700 或 5000 ppm 的 D&C 黄 11 号,持续 105(雄性)或 106(雌性)周;每组 6 至 10 只大鼠在 12 个月时进行评估。这些暴露浓度导致雄性大鼠的平均每日剂量约为 25、85 或 250 mg D&C 黄 11 号/千克体重,雌性大鼠为 25、100 或 280 mg/千克。
存活、体重、饲料消耗和临床发现:给予 1700 或 5000 ppm 的雄性大鼠的存活率显著低于对照组,给予 1700 ppm 的雌性大鼠的存活率显著高于对照组。在整个研究过程中,给予 1700 和 5000 ppm 的雄性和雌性大鼠的平均体重通常低于对照组。暴露组的饲料消耗量与对照组相似。与化学物质相关的临床发现包括,从第 1 天起,所有暴露的雄性和雌性大鼠全身发黄,给予 1700 和 5000 ppm 的雄性大鼠出现头部肿胀和水肿。1 只给予 1700 ppm 和 5 只给予 5000 ppm 的雄性大鼠处于濒死状态,在第 49 至 81 周期间被处死;这些死亡归因于广泛的水肿。
在 12 个月的中期评估中,雄性大鼠出现了一些轻微的血液学变化。有证据表明暴露的雄性大鼠存在轻微贫血;这种贫血的特征是血细胞比容值、血红蛋白浓度和红细胞计数降低。这种轻微贫血的特征为正细胞、正色素性且无反应性。对照和暴露雌性大鼠的血液学参数在生物学或统计学上没有显著差异。
在 12 个月时,所有暴露组雄性和雌性大鼠的绝对和相对肝脏重量均显著大于对照组。在 2 年时,给予 5000 ppm 的雄性大鼠肝细胞腺瘤的发生率以及给予 5000 ppm 的雌性大鼠肝细胞腺瘤或癌(合并)的发生率显著高于对照组。在 12 个月时,给予 1700 和 5000 ppm 的雌性大鼠透明细胞灶的发生率显著高于对照组。在 2 年时,暴露雄性大鼠的混合细胞灶以及暴露雄性(500 ppm 除外)和雌性大鼠的透明细胞灶的发生率显著高于对照组。在 12 个月和 2 年时,暴露雄性和雌性大鼠肝细胞的细胞学改变(嗜碱性和颗粒性)以及胆管上皮、肝细胞和库普弗细胞的色素沉着发生率均高于对照组。在 2 只给予 5000 ppm 的雄性大鼠中观察到肾小管腺瘤,在 1 只给予 1700 ppm 的雄性大鼠中观察到 1 例肾小管癌。在延长评估期间,在另外 2 只给予 5000 ppm 的雄性大鼠、4 只给予 1700 ppm 的雄性大鼠和 2 只给予 500 ppm 的雄性大鼠中观察到肾小管腺瘤。在暴露组雄性大鼠中观察到肾小管增生,而对照组未观察到,标准评估和延长评估中给予 1700 ppm 的雄性大鼠的发生率均显著高于对照组。在 12 个月和 2 年时,在所有对照和暴露的雄性大鼠以及大多数雌性大鼠中均观察到肾小管上皮的坏死和再生。暴露雄性和雌性大鼠的肾病严重程度显著高于对照组。在暴露雄性和给予 1700 ppm 的雌性大鼠 2 年时,肾脏中通常伴随晚期肾病的移行上皮增生发生率高于对照组,且该病变在暴露雄性和雌性大鼠中的严重程度高于对照组。在 12 个月和 2 年时,所有暴露组雄性和雌性大鼠的肾小管色素沉着发生率均显著高于对照组。在 12 个月时,1 只给予 500 ppm 的雄性大鼠出现舌鳞状细胞癌,在 2 年时,1 只给予 5000 ppm 的雌性大鼠出现舌鳞状细胞癌,在每组暴露雄性大鼠以及 1 只给予 5000 ppm 的雌性大鼠 2 年时均观察到 1 例口腔黏膜鳞状细胞癌。在 2 年时,在 1 只对照、1 只给予 500 ppm、2 只给予 1700 ppm 和 4 只给予 5000 ppm 的雄性大鼠的口腔(口腔黏膜或舌)中观察到鳞状细胞乳头状瘤;在 1 只对照和 1 只给予 500 ppm 的雌性大鼠中也观察到该病变。
在一项研究中,基于在菌株 TA100 中使用诱导大鼠肝脏 S9 观察到的反应,D&C 黄 11 号在鼠伤寒沙门氏菌中的致突变性测试结果不明确,而在第二项研究中,基于在菌株 TA98 和 TA100 中使用诱导大鼠或仓鼠肝脏 S9 观察到的反应,结果呈弱阳性。D&C 黄 11 号在有或无 S9 的情况下,均可诱导培养的中国仓鼠卵巢细胞中的姐妹染色单体交换和染色体畸变。在饲料中给予 D&C 黄 11 号 13 周的雄性和雌性 B6C3F(1)小鼠的外周血样本中,未观察到微核正染色红细胞频率增加。
在这种围产期暴露后进行为期 2 年的饲料给药研究的条件下,有一些证据表明 D&C 黄 11 号对雄性 F344/N 大鼠具有致癌活性,这基于肝细胞腺瘤、肾小管肿瘤和口腔鳞状细胞肿瘤发生率的增加。有一些证据表明 D&C 黄 11 号对雌性 F344/N 大鼠具有致癌活性,这基于肝细胞肿瘤发生率的增加。雌性大鼠中罕见的口腔鳞状细胞癌发生率可能与化学处理有关。大鼠在饲料中接触 D&C 黄 11 号 2 年导致非肿瘤性肝脏病变的发生率增加,包括透明细胞灶、雄性和雌性大鼠肝细胞嗜碱性和颗粒性增加以及胆管、肝细胞和库普弗细胞色素沉着,雄性大鼠出现混合细胞灶。在肾脏中,雄性和雌性大鼠的肾小管色素沉着和移行上皮增生发生率增加,雄性大鼠出现肾小管增生。暴露雄性和雌性大鼠的肾病严重程度增加。
2 - (2 - 喹啉基) - 1H - 茚 - 1,3 - (2H) - 二酮;2 - (2 - 喹啉基) - 1,3 - 茚二酮
Arlosol 黄 S、喹啉黄 D(溶于酒精)、喹啉黄 ZSS、C.I. 47000、C.I. 溶剂黄 33、硝基坚牢黄 SL、油黄 SIS、汽油黄 C、喹啉黄 A 醇溶性、喹啉黄碱、喹啉黄醇溶性、喹啉黄 SS'、溶剂黄 33、蜡油黄 T